Neurocrine Biosciences (NBIX) Beats Q1 Earnings and Revenue Estimates

Neurocrine Biosciences (NBIX) came out with quarterly earnings of $1.94 per share, beating the Zacks Consensus Estimate of $1.68 per share. This compares to earnings of $0.08 per share a year ago.